Tectonic Therapeutic Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Tectonic Therapeutic, Inc. (TECX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2014
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2014
Operating Activities
Net Income-57.98-42.82-105.89-8.93-119.71-72.97-46.360.00
Depreciation & Amortization1.651.481.010.361.210.850.380.00
Deferred Income Tax0.000.380.000.000.000.000.000.00
Stock Based Compensation3.491.121.120.640.000.000.000.00
Change in Working Capital-10.28-0.581.841.924.24-2.184.180.00
Change in Accounts Payable-1.42-0.17-1.231.450.000.000.000.00
Change in Other Working Capital-8.86-0.141.230.460.000.000.000.00
Other Operating Activities4.04-0.141.23-6.7015.476.63-0.070.00
Net Cash from Operating Activities-59.08-40.68-27.64-12.45-98.80-67.67-37.650.00
Investing Activities
Capital Expenditures-0.16-0.28-2.09-2.121.181.59-1.830.00
Sales/Maturities of Investments0.001.350.000.000.000.000.000.00
Other Investing Activities0.001.350.000.000.000.000.000.00
Net Cash from Investing Activities-0.16-0.28-2.09-2.12-1.18-1.59-1.830.00
Financing Activities
Debt Repayment-0.48-0.50-0.39-0.390.000.000.000.00
Common Stock Issued94.6034.130.200.000.00129.49162.270.00
Other Financing Activities77.590.000.000.000.000.00-2.000.00
Net Cash from Financing Activities171.7133.7537.6341.420.270.50160.290.00
Summary
Effect of Forex Changes on Cash-0.010.020.000.000.000.000.000.00
Net Change in Cash112.47-7.217.9026.84-99.71-68.75120.810.00
Cash at Beginning of Period29.3636.5528.651.81187.54126.795.990.00
Cash at End of Period141.8329.3636.5528.6587.8358.04126.790.00
Free Cash Flow-59.24-40.96-29.73-14.58-99.98-69.25-39.480.00
Supplemental Disclosures
Interest Paid0.000.001.430.100.000.000.000.00